Dan G. Duda, DMD, Ph.D., of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at ...
( MENAFN - Daily News Egypt) Egypt's Ministry of health and Population announced the inclusion of a new immunotherapy drug to ...
Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...
How would you summarize your study for a lay audience? Immunotherapy has revolutionized the management of cancer, including liver malignancies. However, the benefits are limited by multiple mechanisms ...
She had a fast-growing breast cancer that had spread to her liver and lymphnodes. Chemotherapy successfully got rid of the ...
More than ever, a multidisciplinary approach for liver cancer management is critical to ensure all patients are considered for LT where appropriate, and do not miss the opportunity for long-term ...
Medications are dispensed to patients with “liver cancer” through 22 units for the treatment of hepatitis viruses located in national institutes: ministry ...
Dan G. Duda, DMD, PhD, of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at Massachusetts General Hospital, is the corresponding author of a paper published in ...